Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01221103 | Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL) | unknown | Phase 1 / Phase 2 | 50 | Southern Europe New Drug OrganizationOTHER | 1 | Sep 13, 2011 | clinicaltrials |
| NCT00795977 | Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 20 | Fukushima Medical UniversityOTHER | 1 | Sep 8, 2011 | clinicaltrials |
| NCT01149902 | Study of Chemo-Immunotherapy in Head and Neck Cancer Patients | unknown | Phase 1 | 10 | University of YamanashiOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00431990 | A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma | unknown | Phase 1 / Phase 2 | 40 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Aug 12, 2011 | clinicaltrials |
| NCT01002703 | Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma | unknown | Phase 1 / Phase 2 | 50 | University of LeipzigOTHER | 1 | Aug 12, 2011 | clinicaltrials |
| NCT01016574 | Evaluating the Adequacy of Giro-Couch to Support Prone Breast Boost Irradiation Using IMRT Technique With IGRT.(IN902) | unknown | Phase 1 | 15 | Azimuth Therapy Ltd.INDUSTRY | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00632333 | Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer | unknown | Phase 1 | 9 | Teikyo UniversityOTHER | 1 | Jul 21, 2011 | clinicaltrials |
| NCT00625430 | A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer(FP253-GDEPT) | unknown | Phase 1 | 18 | Biotech Equity Partners Pty LtdINDUSTRY | 1 | Jul 11, 2011 | clinicaltrials |
| NCT00689195 | Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma(OSCAT) | unknown | Phase 1 / Phase 2 | 24 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00753727 | Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma(SUNXRT) | unknown | Phase 1 / Phase 2 | 26 | Australasian Sarcoma Study GroupOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT01225471 | Novel Peptide Vaccination for Patients With Advanced Prostate Cancer | unknown | Phase 1 / Phase 2 | 30 | Iwate Medical UniversityOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00891280 | Dose-escalation Study of Oral CX-4945 | unknown | Phase 1 | 55 | Cylene PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT01199718 | Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma | unknown | Phase 1 | 22 | Cylene PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT01361529 | Safety Study of FLP Injection to Treat Tumor Patients | unknown | Phase 1 | 30 | Acea Bio (Hangzhou) Co., Ltd.INDUSTRY | 1 | May 27, 2011 | clinicaltrials |
| NCT00392470 | Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer | unknown | Phase 1 | 20 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | May 25, 2011 | clinicaltrials |
| NCT01324856 | Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Cephalic Duodenopancreatectomy(PanAm) | unknown | Phase 1 | 100 | University of BelgradeOTHER | 1 | Apr 11, 2011 | clinicaltrials |
| NCT01181193 | Vitamin D for Treatment of Glioblastoma Multiforme | unknown | Phase 1 / Phase 2 | 20 | Soroka University Medical CenterOTHER | 1 | Mar 29, 2011 | clinicaltrials |
| NCT01203735 | Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 20 | Soroka University Medical CenterOTHER | 1 | Mar 29, 2011 | clinicaltrials |
| NCT00635557 | Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme | unknown | Phase 1 / Phase 2 | 30 | Myrexis Inc.INDUSTRY | 1 | Mar 25, 2011 | clinicaltrials |
| NCT01322776 | Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma | unknown | Phase 1 / Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Mar 25, 2011 | clinicaltrials |
| NCT00862303 | DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 100 | Fuzhou General HospitalOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00879489 | Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 24 | Quantum Immunologics, Inc.OTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT01278810 | Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients | unknown | Phase 1 | 30 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 28, 2011 | clinicaltrials |
| NCT00930475 | Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 54 | Charite University, Berlin, GermanyOTHER | 1 | Jan 26, 2011 | clinicaltrials |
| NCT00357617 | Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery | unknown | Phase 1 / Phase 2 | 24 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01266707 | Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma | unknown | Phase 1 | 9 | Fukushima Medical UniversityOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01266720 | HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1) | unknown | Phase 1 | 6 | Fukushima Medical UniversityOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01235845 | Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma | unknown | Phase 1 / Phase 2 | 30 | Qingdao UniversityOTHER | 1 | Dec 3, 2010 | clinicaltrials |
| NCT01240005 | Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Qingdao UniversityOTHER | 1 | Nov 15, 2010 | clinicaltrials |
| NCT00935597 | Host Dendritic Cells in Allograft Patients | unknown | Phase 1 | 25 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 29, 2010 | clinicaltrials |
| NCT01219192 | Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure | unknown | Phase 1 | 24 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 28, 2010 | clinicaltrials |
| NCT00768911 | CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme | unknown | Phase 1 | 30 | Adnexus, A Bristol-Myers Squibb R&D CompanyINDUSTRY | 1 | Oct 27, 2010 | clinicaltrials |
| NCT00874328 | A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 74 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 25, 2010 | clinicaltrials |
| NCT01226030 | Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors | unknown | Phase 1 | 24 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 21, 2010 | clinicaltrials |
| NCT01218880 | Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer | unknown | Phase 1 | 21 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 19, 2010 | clinicaltrials |
| NCT01220544 | Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells | unknown | Phase 1 / Phase 2 | 30 | Charite University, Berlin, GermanyOTHER | 1 | Oct 14, 2010 | clinicaltrials |
| NCT01220284 | Satraplatin and Vinorelbine in Advanced Solid Tumors | unknown | Phase 1 | 27 | Southern Europe New Drug OrganizationOTHER | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00179816 | Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors | unknown | Phase 1 / Phase 2 | 12 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Oct 11, 2010 | clinicaltrials |
| NCT00811759 | Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 58 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Oct 7, 2010 | clinicaltrials |
| NCT00367250 | Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer | unknown | Phase 1 | 32 | Medical University of ViennaOTHER | 1 | Sep 28, 2010 | clinicaltrials |
| NCT00669292 | PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer | unknown | Phase 1 / Phase 2 | 29 | Wakayama Medical UniversityOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00915850 | Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) | unknown | Phase 1 / Phase 2 | 32 | Wakayama Medical UniversityOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT01182831 | Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas | unknown | Phase 1 | 100 | Asian Institute of Gastroenterology, IndiaOTHER | 1 | Aug 30, 2010 | clinicaltrials |
| NCT01175096 | Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor | unknown | Phase 1 / Phase 2 | 20 | Guangdong Provincial People's HospitalOTHER | 1 | Aug 4, 2010 | clinicaltrials |
| NCT01166035 | Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors(TEXO) | unknown | Phase 1 / Phase 2 | 20 | Medical University InnsbruckOTHER | 1 | Jul 20, 2010 | clinicaltrials |
| NCT00868478 | The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) | unknown | Phase 1 / Phase 2 | 15 | Kaplan Medical CenterOTHER | 1 | Jun 2, 2010 | clinicaltrials |
| NCT00003073 | Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors | unknown | Phase 1 | 15 | Pacira Pharmaceuticals, IncINDUSTRY | 2 | Mar 23, 2010 | clinicaltrials |
| NCT00314925 | Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features | unknown | Phase 1 | 60 | NeotropixINDUSTRY | 1 | Feb 25, 2010 | clinicaltrials |
| NCT00915369 | A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer | unknown | Phase 1 | 24 | Fresenius Kabi Oncology Ltd.INDUSTRY | 1 | Feb 8, 2010 | clinicaltrials |
| NCT01063387 | Prophylactic Irradiation of the Para-Aortic Lymph Nodes and Supraclavicular Lymph Nodes in Locally Advanced Uterine Cervical Cancer | unknown | Phase 1 | 200 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 5, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Sep 13, 2011source: clinicaltrials